Skip to main content

Advertisement

ADVERTISEMENT

Asthma News

News
06/20/2023
Julie Gould
“Our results consolidate the strategic position of dupilumab in its role as an excellent therapeutic option currently available within the context of modern biological treatments of severe asthma and CRSwNP, frequently driven by type 2 airway...
“Our results consolidate the strategic position of dupilumab in its role as an excellent therapeutic option currently available within the context of modern biological treatments of severe asthma and CRSwNP, frequently driven by type 2 airway...
“Our results consolidate the...
06/20/2023
First Report Managed Care
News
04/21/2023
Jolynn Tumolo
Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.
Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.
Findings from a phase 3 study...
04/21/2023
First Report Managed Care

Advertisement

News
12/01/2022
Jolynn Tumolo
A post hoc analysis showed long-term treatment with a systemic therapy option was efficacious and safe in patients with asthma who had coexisting chronic rhinosinusitis and/or nasal polyps.
A post hoc analysis showed long-term treatment with a systemic therapy option was efficacious and safe in patients with asthma who had coexisting chronic rhinosinusitis and/or nasal polyps.
A post hoc analysis showed...
12/01/2022
First Report Managed Care
News
11/22/2022
Jolynn Tumolo
Study authors evaluated whether emergency department costs were associated with the likelihood of a 7-day revisit for another asthma exacerbation.
Study authors evaluated whether emergency department costs were associated with the likelihood of a 7-day revisit for another asthma exacerbation.
Study authors evaluated whether...
11/22/2022
First Report Managed Care
News
11/14/2022
Jolynn Tumolo
Study authors assessed data regarding perceptions, experiences, and concerns of adult patients and caregivers of children with asthma.
Study authors assessed data regarding perceptions, experiences, and concerns of adult patients and caregivers of children with asthma.
Study authors assessed data...
11/14/2022
First Report Managed Care

Advertisement

News
10/20/2022
Maria Asimopoulos
Using claims data from Medicare Advantage, Managed Medicaid, and commercial insurance plans, researchers identified the costs associated with severe, persistent asthma.
Using claims data from Medicare Advantage, Managed Medicaid, and commercial insurance plans, researchers identified the costs associated with severe, persistent asthma.
Using claims data from Medicare...
10/20/2022
First Report Managed Care
News
10/07/2022
Jolynn Tumolo
Authors explored whether it is effective to increase short-term use of inhaled corticosteroids during an asthma attack to prevent the use of rescue oral steroids.
Authors explored whether it is effective to increase short-term use of inhaled corticosteroids during an asthma attack to prevent the use of rescue oral steroids.
Authors explored whether it is...
10/07/2022
First Report Managed Care
News
09/23/2022
Jolynn Tumolo
“This study highlights the potential of a digital health tool to support asthma management and physician-patient interactions and discussions around inhaler technique and adherence," researchers said.
“This study highlights the potential of a digital health tool to support asthma management and physician-patient interactions and discussions around inhaler technique and adherence," researchers said.
“This study highlights the...
09/23/2022
First Report Managed Care

Advertisement

News
09/02/2022
Edan Stanley
“Insight into the impact of adherence on the burden of asthma is important for health care stakeholders and can assist in directing future efforts to improve clinical and economic outcomes for patients with asthma,” said researchers.
“Insight into the impact of adherence on the burden of asthma is important for health care stakeholders and can assist in directing future efforts to improve clinical and economic outcomes for patients with asthma,” said researchers.
“Insight into the impact of...
09/02/2022
First Report Managed Care
News
08/25/2022
Jolynn Tumolo
An analysis showed agents that target interleukins are significantly associated with reduced rates of asthma exacerbation for patients with severe disease.
An analysis showed agents that target interleukins are significantly associated with reduced rates of asthma exacerbation for patients with severe disease.
An analysis showed agents that...
08/25/2022
First Report Managed Care

Advertisement